Literature DB >> 19005473

Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule.

C J VandenBussche1, T J Mulrooney, W R Frazier, S Dakshanamurthy, C K Hurley.   

Abstract

Using flow cytometry, fluorescent microscopy and examination of receptor glycosylation status, we demonstrate that an entire killer cell immunoglobulin-like receptor (KIR) locus (KIR2DS3)--assumed earlier to be surface expressed--appears to have little appreciable surface expression in transfected cells. This phenotype was noted for receptors encoded by three allelic variants including the common KIR2DS3*001 allele. Comparing the surface expression of KIR2DS3 with that of the better-studied KIR2DS1 molecule in two different cell lines, mutational analysis identified multiple polymorphic amino-acid residues that significantly alter the proportion of molecules present on the cell surface. A simultaneous substitution of five residues localized to the leader peptide (residues -18 and -7), second domain (residues 123 and 150) and transmembrane region (residue 234) was required to restore KIR2DS3 to the expression level of KIR2DS1. Corresponding simultaneous substitutions of KIR2DS1 to the KIR2DS3 residues resulted in a dramatically decreased surface expression. Molecular modeling was used to predict how these substitutions contribute to this phenotype. Alterations in receptor surface expression are likely to affect the balance of immune cell signaling impacting the characteristics of the response to pathogens or malignancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005473      PMCID: PMC3487464          DOI: 10.1038/gene.2008.91

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  31 in total

Review 1.  The IMGT/HLA and IPD databases.

Authors:  James Robinson; Matthew J Waller; Sylvie C Fail; Steven G E Marsh
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

2.  Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.

Authors:  Mariella Della Chiesa; Elisa Romeo; Michela Falco; Mirna Balsamo; Raffaella Augugliaro; Lorenzo Moretta; Cristina Bottino; Alessandro Moretta; Massimo Vitale
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

3.  Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules.

Authors:  R Biassoni; A Pessino; A Malaspina; C Cantoni; C Bottino; S Sivori; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

4.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.

Authors:  Q R Fan; L Mosyak; C C Winter; N Wagtmann; E O Long; D C Wiley
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

6.  A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.

Authors:  C C Winter; E O Long
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

7.  Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.

Authors:  Melissa R Snyder; Takako Nakajima; Paul J Leibson; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.

Authors:  Noriko K Steiner; Sivanesan Dakshanamurthy; Christopher J VandenBussche; Carolyn K Hurley
Journal:  Immunogenetics       Date:  2008-08-06       Impact factor: 2.846

9.  The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site.

Authors:  Jianwen Feng; Matthew E Call; Kai W Wucherpfennig
Journal:  PLoS Biol       Date:  2006-04-25       Impact factor: 8.029

10.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Ann-Margaret Little; Fotini Partheniou; Peter Parham
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  45 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

2.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

3.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 4.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

5.  DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells.

Authors:  Tiernan J Mulrooney; Phillip E Posch; Carolyn Katovich Hurley
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

6.  The extracellular domain of Notch2 increases its cell-surface abundance and ligand responsiveness during kidney development.

Authors:  Zhenyi Liu; Shuang Chen; Scott Boyle; Yu Zhu; Andrew Zhang; David R Piwnica-Worms; Ma Xenia G Ilagan; Raphael Kopan
Journal:  Dev Cell       Date:  2013-06-24       Impact factor: 12.270

7.  A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs.

Authors:  K Czaja; A-S Borer; L Schmied; G Terszowski; M Stern; A Gonzalez
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

8.  Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.

Authors:  Neda Nemat-Gorgani; Hugo G Hilton; Brenna M Henn; Meng Lin; Christopher R Gignoux; Justin W Myrick; Cedric J Werely; Julie M Granka; Marlo Möller; Eileen G Hoal; Makoto Yawata; Nobuyo Yawata; Lies Boelen; Becca Asquith; Peter Parham; Paul J Norman
Journal:  J Immunol       Date:  2018-03-16       Impact factor: 5.422

9.  Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.

Authors:  Ketevan Gendzekhadze; Paul J Norman; Laurent Abi-Rached; Thorsten Graef; Achim K Moesta; Zulay Layrisse; Peter Parham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-16       Impact factor: 11.205

10.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

Authors:  Thorsten Graef; Achim K Moesta; Paul J Norman; Laurent Abi-Rached; Luca Vago; Anastazia M Older Aguilar; Michael Gleimer; John A Hammond; Lisbeth A Guethlein; David A Bushnell; Philip J Robinson; Peter Parham
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.